Management of Pancreatic Cancer Symptoms

Introduction to Symptom Management

The American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) guidelines for metastatic pancreatic cancer do not recommend the use of antispasmodics like Buscopan for symptom management 1, 2, 3

The American Society of Clinical Oncology (ASCO) recommends opioids as the cornerstone of treatment for pancreatic cancer pain, with morphine as the first-line medication for moderate to severe pain 4, 5, 7
Oral morphine is titrated individually with doses every 4 hours plus rescue doses (up to every hour) for breakthrough pain 7
Alternatives to morphine include tramadol and fentanyl, depending on pain intensity and renal function 4, 5, 7
Non-opioid analgesics like paracetamol and NSAIDs can be used for mild pain or as adjuvants 4, 5, 7
Adjuvant medications for neuropathic pain, such as gabapentine, pregabaline, nortriptyline, and duloxetine, may be necessary due to the proximity of the tumor to the celiac axis 4, 5, 6, 8

Celiac plexus block should be considered when medications are ineffective or cause intolerable side effects 3, 4, 5, 9
Neurolysis of the celiac plexus can significantly improve pain compared to standard treatment for up to 6 months 9
Early block can provide better pain control, less opioid consumption, and improved quality of life 4, 5
Hypofractionated radiotherapy may improve pain control and reduce analgesic consumption 3

For nausea, vomiting, and early satiety due to gastric/duodenal obstruction, metoclopramide can be used as a prokinetic to accelerate gastric emptying 1, 2, 3
Endoscopic duodenal stent placement can be successful in the majority of patients, with a median patency duration of 6 months 1, 2
Endoscopic placement of a self-expandable biliary stent is the preferred treatment for relieving jaundice and pruritus 1, 2
Pancreatic enzyme replacement (pancreatin) can improve digestion and nutrient absorption, with demonstrated weight gain 2, 5
For malignant ascites, intermittent paracentesis can provide symptomatic relief (duration approximately 3 days) 1, 2
Spironolactone can reduce reaccumulation of ascites 1, 2
A permanent drainage catheter may be necessary if paracentesis is required frequently (more than once a week) 1, 2

Patients with metastatic pancreatic cancer should undergo comprehensive assessment of symptom burden, psychological status, and social support at the first visit, with formal palliative care consultation in most cases 10, 4, 6